PBC Clinical Trials

Saroglitazar for the Treatment of Primary Biliary Cholangitis (PBC)

A multicenter, randomized, double-blind, placebo controlled, phase 2b/3 study to evaluate the efficacy and safety of saroglitazar magnesium in subjects with primary biliary cholangitis

ClinicalTrials.gov Identifier: NCT05133336

Visit clinicaltrials.gov Test

Saroglitazar for the Treatment of Primary Biliary Cholangitis (PBC)

A multicenter, randomized, double-blind, placebo controlled, phase 2b/3 study to evaluate the efficacy and safety of saroglitazar magnesium in subjects with primary biliary cholangitis

ClinicalTrials.gov Identifier: NCT05133336

Visit clinicaltrials.gov
Contact Us